Goldman Sachs US Sanctions Have Limited Impact on Russias Crude Exports Oil Prices Dip Indian Corporate Balance Sheets Show Maturity as Interest Coverage Ratios Strengthen SP 500 Edges Higher as Healthcare and Tech Rally Outweigh Communication Services Dip Egypt QatarEnergy and ExxonMobil Partner to Ship Cypriot Gas to Europe via Egyptian LNG Facilities US Pauses Arms Sales to Taiwan Amid Iran Conflict Acting Navy Chief Indicates Trump Skips Sons Wedding as Family Health Revelation Emerges Nicolet Bankshares Q1 2026 Earnings Earnings Miss Estimates by Wide Margin Amid Challenging Environment Moving iMage Technologies Inc MITQ Q1 2026 Earnings Net Loss Reported as Stock Edges Higher FLR Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Edges Higher BTQ Technologies Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises 1183 GKOS Q1 2026 Earnings EPS Beat Masks Broader Concerns as Stock Drops 135 PEW Q1 2026 Earnings Loss Narrows Sharply Stock Slips on Mixed Sentiment BlackRock Capital Allocation Term Trust BCAT Modestly Gains as Price Hovers Near MidRange Assurant Inc AIZ Navigates Slight Decline While Holding Key Support Levels MIND CTI Ltd MNDO Edges Higher Amid Consolidation Key Levels to Watch Eaton Vance Global Diversified Equity Income Fund EXG Modest Pullback as Shares Test Support Zone Republic Airways Slides 218 Approaches Key Support as Regional Airline Sector Weakens Cambium Networks CMBM Q3 2024 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid Demand Uncertainty PRIM Q1 2026 Earnings EPS Misses Estimate by 315 Stock Still Climbs 69 Valaris Limited VAL Q1 2026 Earnings EPS Misses Wide Stock Holds Steady BODI Q1 2026 Earnings EPS Surges to 030 Smashing Estimates by 2634 Community Healthcare Trust Incorporated CHCT Q1 2026 Earnings Massive Earnings Surprise as Profitability Rebounds Sharply KR Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Union Bank Board Approves Up to 8000 Crore Capital Raise via Equity and Debt KGS Q1 2026 Earnings EPS Surprise Drives Optimism Despite Slight Stock Decline Inhibikase Therapeutics IKT Recovers 35 as Buyers Defend Key Support Level